What is Integral Diagnostics Price-to-Free-Cash-Flow?
As of today (2024-05-11), Integral Diagnostics's share price is $2.10.
Integral Diagnostics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.06. Hence, Integral Diagnostics's Price-to-Free-Cash-Flow Ratio for today is 36.84.
The historical rank and industry rank for Integral Diagnostics's Price-to-Free-Cash-Flow or its related term are showing as below:
ITGDF'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.02 Med: 27.79 Max: 78.18
Current: 43.76
During the past 8 years, Integral Diagnostics's highest Price-to-Free-Cash-Flow Ratio was 78.18. The lowest was 12.02. And the median was 27.79.
ITGDF's Price-to-Free-Cash-Flow is ranked worse than 57.3% of 89
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.82
vs ITGDF: 43.76
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Integral Diagnostics was 13.50% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -8.20% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -2.70% per year.
During the past 8 years, Integral Diagnostics's highest 3-Year average Free Cash Flow per Share Growth Rate was 34.90% per year. The lowest was -22.10% per year. And the median was 24.70% per year.
Integral Diagnostics Price-to-Free-Cash-Flow Historical Data
The historical data trend for Integral Diagnostics's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Integral Diagnostics Price-to-Free-Cash-Flow Chart
Competitive Comparison of Integral Diagnostics's Price-to-Free-Cash-Flow
For the Diagnostics & Research subindustry, Integral Diagnostics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integral Diagnostics's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Integral Diagnostics's Price-to-Free-Cash-Flow falls into.
Integral Diagnostics Price-to-Free-Cash-Flow Calculation
Integral Diagnostics's Share Price of today is $2.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Integral Diagnostics (OTCPK:ITGDF) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Integral Diagnostics Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Integral Diagnostics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Integral Diagnostics (Integral Diagnostics) Business Description
Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
Integral Diagnostics (Integral Diagnostics) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ITGDF has been successfully added to your 